Wilmington, DE -- (SBWIRE) -- 02/13/2014 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding FireEye, Inc. (NASDAQ:FEYE) and Seattle Genetics Inc. (NASDAQ:SGEN).
FireEye, Inc. (NASDAQ:FEYE) a company that invented a purpose-built, virtual machine-based security platform that provides real-time protection to enterprises and governments worldwide against the next generation of cyber attacks closed down in its previous session (-11.45%) on 4,448,897 shares traded after FireEye Reported Financial Results for Fourth Quarter and Fiscal Year 2013. FireEye, Inc. (NASDAQ:FEYE) is currently down (-14.03%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about FireEye, Inc. (NASDAQ:FEYE)
Seattle Genetics Inc. (NASDAQ:SGEN) a biotechnology company that focuses on the development and commercialization of monoclonal antibody-based therapies for cancer closed up in its previous session (+10.72%) on 4,021,587 shares traded after Seattle Genetics Reported Fourth Quarter and Year 2013 Financial Results. Seattle Genetics Inc. (NASDAQ:SGEN) is currently up (+95.38%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List.
Click Here to find out what other Investors are saying about Seattle Genetics Inc. (NASDAQ:SGEN)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report